118 related articles for article (PubMed ID: 24969441)
1. A risk scoring system to determine recurrence in early-stage type 1 endometrial cancer: a French multicentre study.
Bendifallah S; Canlorbe G; Huguet F; Coutant C; Hudry D; Graesslin O; Raimond E; Touboul C; Collinet P; Bleu G; Daraï E; Ballester M
Ann Surg Oncol; 2014 Dec; 21(13):4239-45. PubMed ID: 24969441
[TBL] [Abstract][Full Text] [Related]
2. French Multicenter Study Evaluating the Risk of Lymph Node Metastases in Early-Stage Endometrial Cancer: Contribution of a Risk Scoring System.
Bendifallah S; Canlorbe G; Arsène E; Collinet P; Huguet F; Coutant C; Hudry D; Graesslin O; Raimond E; Touboul C; Daraï E; Ballester M
Ann Surg Oncol; 2015 Aug; 22(8):2722-8. PubMed ID: 25564162
[TBL] [Abstract][Full Text] [Related]
3. A Predictive Model Using Histopathologic Characteristics of Early-Stage Type 1 Endometrial Cancer to Identify Patients at High Risk for Lymph Node Metastasis.
Bendifallah S; Canlorbe G; Laas E; Huguet F; Coutant C; Hudry D; Graesslin O; Raimond E; Touboul C; Collinet P; Cortez A; Bleu G; Daraï E; Ballester M
Ann Surg Oncol; 2015 Dec; 22(13):4224-32. PubMed ID: 25869227
[TBL] [Abstract][Full Text] [Related]
4. Just how accurate are the major risk stratification systems for early-stage endometrial cancer?
Bendifallah S; Canlorbe G; Collinet P; Arsène E; Huguet F; Coutant C; Hudry D; Graesslin O; Raimond E; Touboul C; Daraï E; Ballester M
Br J Cancer; 2015 Mar; 112(5):793-801. PubMed ID: 25675149
[TBL] [Abstract][Full Text] [Related]
5. Absolute depth of myometrial invasion in endometrial cancer is superior to the currently used cut-off value of 50%.
Geels YP; Pijnenborg JM; van den Berg-van Erp SH; Snijders MP; Bulten J; Massuger LF
Gynecol Oncol; 2013 May; 129(2):285-91. PubMed ID: 23422503
[TBL] [Abstract][Full Text] [Related]
6. An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer.
Gadducci A; Cosio S; Fanucchi A; Cristofani R; Genazzani AR
Anticancer Res; 2000; 20(3B):1977-84. PubMed ID: 10928137
[TBL] [Abstract][Full Text] [Related]
7. Tumor Size, an Additional Prognostic Factor to Include in Low-Risk Endometrial Cancer: Results of a French Multicenter Study.
Canlorbe G; Bendifallah S; Laas E; Raimond E; Graesslin O; Hudry D; Coutant C; Touboul C; Bleu G; Collinet P; Cortez A; Daraï E; Ballester M
Ann Surg Oncol; 2016 Jan; 23(1):171-7. PubMed ID: 25952272
[TBL] [Abstract][Full Text] [Related]
8. A clue towards improving the European Society of Medical Oncology risk group classification in apparent early stage endometrial cancer? Impact of lymphovascular space invasion.
Bendifallah S; Canlorbe G; Raimond E; Hudry D; Coutant C; Graesslin O; Touboul C; Huguet F; Cortez A; Daraï E; Ballester M
Br J Cancer; 2014 May; 110(11):2640-6. PubMed ID: 24809776
[TBL] [Abstract][Full Text] [Related]
9. Tumour-free distance from serosa is a better prognostic indicator than depth of invasion and percentage myometrial invasion in endometrioid endometrial cancer.
Chattopadhyay S; Galaal KA; Patel A; Fisher A; Nayar A; Cross P; Naik R
BJOG; 2012 Sep; 119(10):1162-70. PubMed ID: 22804815
[TBL] [Abstract][Full Text] [Related]
10. Prospective evaluation of prognostic significance of the tumor-free distance from uterine serosa in surgically staged endometrial adenocarcinoma.
Schwab KV; O'Malley DM; Fowler JM; Copeland LJ; Cohn DE
Gynecol Oncol; 2009 Jan; 112(1):146-9. PubMed ID: 18937970
[TBL] [Abstract][Full Text] [Related]
11. Risk-scoring system for the individualized prediction of lymphatic dissemination in patients with endometrioid endometrial cancer.
AlHilli MM; Podratz KC; Dowdy SC; Bakkum-Gamez JN; Weaver AL; McGree ME; Keeney GL; Cliby WA; Mariani A
Gynecol Oncol; 2013 Oct; 131(1):103-8. PubMed ID: 23845691
[TBL] [Abstract][Full Text] [Related]
12. The significance of the amount of myometrial invasion in patients with Stage IB endometrial carcinoma.
Alektiar KM; McKee A; Lin O; Venkatraman E; Zelefsky MJ; Mychalczak BR; McKee B; Hoskins WJ; Barakat RR
Cancer; 2002 Jul; 95(2):316-21. PubMed ID: 12124832
[TBL] [Abstract][Full Text] [Related]
13. Call for Surgical Nodal Staging in Women with ESMO/ESGO/ESTRO High-Intermediate Risk Endometrial Cancer: A Multicentre Cohort Analysis from the FRANCOGYN Study Group.
Ouldamer L; Bendifallah S; Body G; Canlorbe G; Touboul C; Graesslin O; Raimond E; Collinet P; Coutant C; Lavoué V; Lévêque J; Daraï E; Ballester M;
Ann Surg Oncol; 2017 Jun; 24(6):1660-1666. PubMed ID: 28058558
[TBL] [Abstract][Full Text] [Related]
14. Honing the classification of high-risk endometrial cancer with inclusion of lymphovascular space invasion.
Bendifallah S; Perrin M; Ouldamer L; Lavoué V; Canlorbe G; Raimond E; Hudry D; Coutant C; Graesslin O; Touboul C; Collinet P; Daraï E; Ballester M;
Surg Oncol; 2017 Mar; 26(1):1-7. PubMed ID: 28317578
[TBL] [Abstract][Full Text] [Related]
15. Endometrial cancer: prognostic significance of risk classification based on pre-intraoperative findings.
Maneschi F; Ceccacci I; Perugini A; Pane C; Simeone A; Manicone A
Arch Gynecol Obstet; 2012 Feb; 285(2):521-7. PubMed ID: 21779772
[TBL] [Abstract][Full Text] [Related]
16. Clinical outcomes in international federation of gynecology and obstetrics stage IA endometrial cancer with myometrial invasion treated with or without postoperative vaginal brachytherapy.
Diavolitsis V; Rademaker A; Lurain J; Hoekstra A; Strauss J; Small W
Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):415-9. PubMed ID: 22365625
[TBL] [Abstract][Full Text] [Related]
17. L1 cell adhesion molecule is a strong predictor for distant recurrence and overall survival in early stage endometrial cancer: pooled PORTEC trial results.
Bosse T; Nout RA; Stelloo E; Dreef E; Nijman HW; Jürgenliemk-Schulz IM; Jobsen JJ; Creutzberg CL; Smit VT
Eur J Cancer; 2014 Oct; 50(15):2602-10. PubMed ID: 25126672
[TBL] [Abstract][Full Text] [Related]
18. The importance of adjuvant chemotherapy and pelvic radiotherapy in high-risk early stage endometrial carcinoma.
Jutzi L; Hoskins P; Lim P; Aquino-Parsons C; Tinker A; Kwon JS
Gynecol Oncol; 2013 Dec; 131(3):581-5. PubMed ID: 24055614
[TBL] [Abstract][Full Text] [Related]
19. Significance of adenomyosis on tumor progression and survival outcome of endometrial cancer.
Matsuo K; Cahoon SS; Gualtieri M; Scannell CA; Jung CE; Takano T; Paulson RJ; Muderspach LI; Roman LD
Ann Surg Oncol; 2014 Dec; 21(13):4246-55. PubMed ID: 25001096
[TBL] [Abstract][Full Text] [Related]
20. Temporal pattern of recurrence of stage I endometrial cancer in relation to histological risk factors.
Ben Arie A; Lavie O; Gdalevich M; Voldarsky M; Barak F; Schneider D; Levy T; Anteby E; Gemer O
Eur J Surg Oncol; 2012 Feb; 38(2):166-9. PubMed ID: 22056646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]